Membrane-Interacting DNA Nanotubes Induce Cancer Cell Death

Area of Science:

• Biotechnology
• Nanotechnology
• Molecular Biology

Background:

• DNA nanotechnology enables precise positioning of biomolecules for targeted drug delivery.
• DNA's negative charge necessitates modification for effective cellular interaction and delivery.
• Cholesterol conjugation is a strategy to enhance DNA nanostructures' interaction with cell membranes.

Purpose of the Study:

• To design and assemble cholesterol-modified DNA nanotubes for cancer cell interaction and apoptosis induction.
• To investigate the mechanism of cell death induced by these modified DNA nanotubes.
• To evaluate the potential of cholesterol-modified DNA nanotubes as cytotoxic agents or drug delivery systems.

Main Methods:

• Synthesis and assembly of cholesterol-modified DNA nanotubes.
• Flow cytometry and confocal microscopy to assess cell binding, uptake, and localization.
• Assays for membrane permeability, caspase activation, and cell death.
• Inhibition studies using caspase inhibitors.

Main Results:

• Cholesterol-modified DNA nanotubes efficiently bind to cancer cell plasma membranes, with binding increasing with cholesterol conjugation.
• The nanotubes are internalized and localized to the endosomal compartment.
• These modified nanotubes increase membrane permeability, caspase activation, and cell death, but cell death is only partially caspase-dependent.
• Cytochrome c conjugation did not enhance cell death rates.

Conclusions:

• Cholesterol-modified DNA nanotubes induce cancer cell death via increased membrane permeability, involving both apoptotic and necrotic pathways.
• The mechanism of cell death is partially dependent on caspase activity.
• These nanostructures hold promise as novel cytotoxic agents or drug delivery platforms leveraging cholesterol-mediated membrane interactions.